News

Families are now facing a postcode lottery over who gets the drug givinostat, which can slow progress of Duchenne muscular ...
In patients showing cognitive decline, a new blood test for Alzheimer's is expected to make diagnosis more convenient, ...
The agency granted clearances for tests for cancer and precancer disorders, infectious respiratory diseases, and risk of sepsis and septic shock, among others.
Mayo Clinic researchers validated an FDA-approved blood test that diagnoses Alzheimer’s disease with 95% sensitivity and 82% ...
The clinical lab giant is working with MD Anderson on an LDT for assessing cancer risk to drive uptake of recommended screenings and identify high-risk individuals for evaluation.
FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.
Much attention has been paid to malaria research conducted on inmates at Illinois' Stateville Penitentiary and the fraught ...
A man had his driver's license revoked after refusing a chemical test during a drug-related arrest, triggering a mandatory ...
A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...
JoEllen Zembruski-Ruple, while in the care of New York City's renowned Memorial Sloan Kettering Cancer Center, swallowed the first three chemotherapy pills to treat her squamous cell carcinoma on Jan.
The promise of this research is huge. With a simple blood test, doctors may soon be able to spot Alzheimer’s earlier, guide ...
Blood tests designed to detect Alzheimer’s disease are being marketed as quick and convenient tools for diagnosing memory ...